 | Highlight 2009.11.9  For Shareholders |
| Utilizing its strengths in antibody technologies and biotechnologies, Kyowa Hakko Kirin is eager to discover new drugs and to contribute to society. |
- 2010.01.29
- 2010.01.29
- 2010.01.22
-
2009.10.29
Kyowa Hakko Kirin Reports Interim Results in line with Revised Forecasts
-
2009.10.22
Kyowa Hakko Kirin: Upward Revision of Sales and Profit Forecasts
- 2009.11.12
-
2009.11.12
Appendix to the Consolidated Financial Statements Fiscal 2009 Interim
(69KB)
- 2009.08.20
-
2009.08.20
Consolidated Financial Summary First Quarter of the Fiscal Period Ending December 2009
(560KB)
-
2009.08.10
Appendix to the Consolidated Financial Statements First Quarter Results for Fiscal 2009
(90KB)
Financial Information through Euroland.com
Corporate Information (English)
Corporate Information (Chinese)
Fact Sheet (English)
Share Graph (English)
Share Price Search (English)